Schonfeld Strategic Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-538,836	Closed	-$62.3M	–	2385
2023 Q3	$62.3M	Buy	538,836 +371,452	+222%	+$39.9M	0.58%	24
2023 Q2	$17.2M	Buy	167,384 +142,842	+582%	+$15.1M	0.15%	212
2023 Q1	$2.68M	Sell	24,542 -127,990	-84%	-$14.1M	0.03%	610
2022 Q4	$17.4M	Sell	152,532 -7,811	-5%	-$649K	0.14%	205
2022 Q3	$9.92M	Buy	160,343 +44,422	+38%	+$3.1M	0.08%	310
2022 Q2	$9.24M	Buy	115,921 +57,881	+100%	+$5.48M	0.1%	292
2022 Q1	$6.11M	Buy	58,040 +36,840	+174%	+$3.59M	0.07%	387
2021 Q4	$2.28M	Sell	21,200 -47,909	-69%	-$5.23M	0.02%	669
2021 Q3	$7.57M	Buy	69,109 +16,392	+31%	+$1.7M	0.09%	325
2021 Q2	$4.94M	Buy	52,717 +11,154	+27%	+$1.03M	0.06%	467
2021 Q1	$3.83M	Buy	41,563 +18,263	+78%	+$1.54M	0.05%	501
2020 Q4	$1.7M	Sell	23,300 -109,175	-82%	-$8.12M	0.02%	644
2020 Q3	$10.3M	Buy	132,475 +87,663	+196%	+$6.03M	0.21%	140
2020 Q2	$2.49M	Buy	44,812 +17,845	+66%	+$763K	0.07%	349
2020 Q1	$799K	Sell	26,967 -18,442	-41%	-$624K	0.05%	435
2019 Q4	$1.65M	Sell	45,409 -186,573	-80%	-$5.72M	0.04%	375
2019 Q3	$6.32M	Buy	231,982 +159,443	+220%	+$4.12M	0.19%	142
2019 Q2	$1.75M	Buy	+72,539	New	+$1.84M	0.06%	317
2017 Q1	–	Sell	-20,000	Closed	-$324K	–	809
2016 Q4	$324K	Sell	20,000 -13,109	-40%	-$238K	0.04%	411
2016 Q3	$600K	Buy	33,109 +21,636	+189%	+$423K	0.1%	248
2016 Q2	$189K	Sell	11,473 -65,902	-85%	-$1.07M	0.04%	382
2016 Q1	$1.28M	Buy	+77,375	New	+$1.35M	0.52%	48

Other funds holding HZNP